Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.22.4
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenues, net of slotting and promotion $ 13,369 $ 79,374 $ 93,339 $ 193,827
Operating expenses        
Cost of product sold 41,996 88,105 167,117 212,979
Advertising and promotional 53,169 158,040 90,335 465,791
Selling, general and administrative expense 104,292 72,316 230,636 344,953
Professional fees 491,448 239,303 841,397 482,169
Total operating expenses 690,908 557,764 1,329,485 1,505,892
Loss from operations (677,539) (478,390) (1,236,146) (1,312,065)
Other (income) and expenses        
Interest expense - debt 34,382 4,909 57,328 4,909
Interest expense – financing cost 3,377,927 270,210 3,510,910 270,210
Amortization of debt discount 484,907 12,218 1,029,452 12,218
(Gain) loss on debt extinguishment (14,493) (72,464)
Other expense- non cash 15,192 15,192
Total other (income) expense 3,882,723 302,529 4,525,226 302,529
Provision for income tax
Net Loss (4,560,262) (780,919) (5,761,372) (1,614,594)
Deemed dividend on Series B Preferred Stock 3,340,203 68,722 3,685,665 358,657
Net loss attributable to common shareholders $ (7,900,465) $ (849,641) $ (9,447,037) $ (1,973,251)
Basic and diluted net loss per common share (in Dollars per share) $ (0.08) $ (0.01) $ (0.1) $ (0.02)
Weighted average shares of capital outstanding – basic and diluted (in Shares) 97,436,644 86,407,410 95,075,293 84,400,978